Avvisati G - Search Results

1

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.

Breccia M, Avvisati G, Latagliata R, Carmosino I, Guarini A, De Propris MS, Gentilini F, Petti MC, Cimino G, Mandelli F, Lo-Coco F. Breccia M, et al. Among authors: avvisati g. Leukemia. 2007 Jan;21(1):79-83. doi: 10.1038/sj.leu.2404377. Epub 2006 Aug 24. Leukemia. 2007. PMID: 16932337 Clinical Trial.

2

Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lo Coco F, Mandelli F. Latagliata R, et al. Among authors: avvisati g. Blood. 2002 Feb 1;99(3):822-4. doi: 10.1182/blood.v99.3.822. Blood. 2002. PMID: 11806982 Free article.

3

Advances in the understanding and management of acute promyelocytic leukemia.

Mandelli F, Avvisati G, Lo Coco F. Mandelli F, et al. Among authors: avvisati g. Rev Clin Exp Hematol. 2002 Mar;6(1):60-71; discussion 86-7. doi: 10.1046/j.1468-0734.2002.00061.x. Rev Clin Exp Hematol. 2002. PMID: 12060484 Review.

4

Late relapses in acute promyelocytic leukaemia.

Latagliata R, Carmosino I, Breccia M, Minni A, Testi A, Iorio N, Lo-Coco F, Avvisati G, Petti MC, Mandelli F, Cimino G. Latagliata R, et al. Among authors: avvisati g. Acta Haematol. 2007;117(2):106-8. doi: 10.1159/000097385. Epub 2006 Nov 28. Acta Haematol. 2007. PMID: 17135723

5

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.

Breccia M, Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G, Testi AM, Avvisati G, Petti MC, Minotti C, Latagliata R, Foà R, Pelicci PG, Lo-Coco F. Breccia M, et al. Among authors: avvisati g. Blood. 2012 Jan 5;119(1):49-54. doi: 10.1182/blood-2011-07-369595. Epub 2011 Nov 2. Blood. 2012. PMID: 22049518 Free article.

6

Todisco E, Testi AM, Avvisati G, Moleti ML, Cedrone M, Cimino G, Mancini F, Amadori S, Mandelli F. Todisco E, et al. Among authors: avvisati g. Leukemia. 1995 Sep;9(9):1583-5. Leukemia. 1995. PMID: 7658728

7

Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?

Latagliata R, Spiriti MA, Avvisati G, De Gregoris C, Fazi P, Spadea A, Petti MC. Latagliata R, et al. Among authors: avvisati g. Leuk Res. 1995 Mar;19(3):213-7. doi: 10.1016/0145-2126(94)00140-6. Leuk Res. 1995. PMID: 7700082

8

What is the best treatment for acute promyelocytic leukemia?

Avvisati G, Petti MC, Mandelli F. Avvisati G, et al. Leuk Lymphoma. 1993;11 Suppl 2:29-35. doi: 10.3109/10428199309064259. Leuk Lymphoma. 1993. PMID: 8124230 Review.

9

Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.

Spadea A, Petti MC, Fazi P, Vegna ML, Arcese W, Avvisati G, Aloe Spiriti MA, Latagliata R, Meloni G, Testi AM, et al. Spadea A, et al. Among authors: avvisati g. Leukemia. 1993 Apr;7(4):549-52. Leukemia. 1993. PMID: 8464233 Clinical Trial.

10

Bisantrene in relapsed and refractory acute myelogenous leukemia.

Spadea A, Petti MC, Aloespiriti MA, Avvisati G, De Gregoris C, Fazi P, Latagliata R, Amadori S, Mandelli F. Spadea A, et al. Among authors: avvisati g. Leuk Lymphoma. 1993 Feb;9(3):217-20. doi: 10.3109/10428199309147373. Leuk Lymphoma. 1993. PMID: 8471980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters